methyl 4-((tert-butoxycarbonyl)amino)-2-oxabicyclo[2.2.2]octane-1-carboxylate

Catalog No.: 
ACRIMP615
CAS No.: 
2205097-75-0
Molecular Formula: 
C14H23NO5
Molecular Weight: 
285.16
methyl 4-((tert-butoxycarbonyl)amino)-2-oxabicyclo[2.2.2]octane-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$759.00In stockInquiry
250mg98%$1264.00In stockInquiry
500mg98%$1804.00In stockInquiry
1g98%$2577.00InquiryInquiry
5g98%$7731.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namemethyl 4-((tert-butoxycarbonyl)amino)-2-oxabicyclo[2.2.2]octane-1-carboxylate
IUPAC Namemethyl 4-((tert-butoxycarbonyl)amino)-2-oxabicyclo[2.2.2]octane-1-carboxylate
Molecular FormulaC14H23NO5
Molecular Weight285.16
SMILESO=C(NC12COC(CC1)(CC2)C(OC)=O)OC(C)(C)C
InChI KeyCSBYGAAARQLQFO-UHFFFAOYSA-N
Synonym2-Oxabicyclo[2.2.2]octane-1-carboxylic acid, 4-[[(1,1-dimethylethoxy)carbonyl]amino]-, methyl ester;methyl 4-(tert-butoxycarbonylamino)-2-oxabicyclo[2.2.2]octane-1-carboxylate
CAS No.2205097-75-0

Synthetic Route by SureRoute

1. ACRIMP615 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWTCK432 route compound structure diagram
    ACWTCK4322320469-53-0In Stock
  4. Then
  5. ACRIMP615 route product structure diagram
    ACRIMP6152205097-75-0In Stock
Inquiry

2. ACRIMP615 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRIMP615 route product structure diagram
    ACRIMP6152205097-75-0In Stock
Inquiry

3. ACRIMP615 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRIMP615 route product structure diagram
    ACRIMP6152205097-75-0In Stock
Inquiry

Comments (0)